Haematology

Uzm. Dr. Işıl Erdoğan Özünal

Doctor and researcher Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi İstanbul
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphoma, Large B-Cell, Diffuse
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lymphoma, Large B-Cell, Diffuse 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologysaglik.gov.trFrom source
  • InstitutionGöztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesisaglik.gov.trFrom source
  • Area of workLeukemia, Myelogenous, Chronic, BCR-ABL PositiveExtracted from 4 publications · Model version —From source
  • Publications51 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-5289-7134ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://suleymanyalcinsh.saglik.gov.tr/TR-1493237/doktorlarimiz.html#isil-erdogan-ozunalsaglik.gov.tr

Scientific work

Publications on Leukemia, Myelogenous, Chronic, BCR-ABL Positive

51 publications

  1. Publication Only

    HemaSphere, 2026

    DOI 10.1002/hem3.70421 Open-access full textSource: OpenAlex

  2. A Key Overlooked Medical Condition: Vitamin D Deficiency in Hodgkin Lymphoma

    Cerrahpaşa Medical Journal, 2026

    DOI 10.5152/cjm.2026.26002 Open-access full textSource: ORCID

  3. Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients

    Annals of Hematology, 2025

    DOI 10.1007/s00277-025-06644-z PMID 41074982 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  4. High-density lipoprotein (HDL) has an impact on myeloma outcome: Lower HDL associates with worse progression-free survival

    Wiener Klinische Wochenschrift, 2024

    DOI 10.1007/s00508-023-02239-8 PMID 37402933 4 citations (Europe PMC) Source: ORCID

  5. Serum Lactate Dehydrogenase Elevates and Inversely Correlates with Platelet Count in Immune Thrombocytopenia: A Case-control Study in Adults

    Hamidiye Medical Journal, 2023

    DOI 10.4274/hamidiyemedj.galenos.2023.85057 1 citation (OpenAlex) Open-access full textSource: ORCID

  6. Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?

    The Turkish Journal of Hematology, 2023

    DOI 10.4274/tjh.galenos.2023.2022.0452 PMID 36847696 1 citation (Europe PMC) Open-access full textSource: ORCID

  7. Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_355_22 PMID 37147993 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  8. MM-125 Adipose Tissue Metabolic Activity in Multiple Myeloma

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01406-4 Source: OpenAlex

  9. Diagnostic role of platelet indices and leukocyte count in pseudothrombocytopenia

    Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, 2022

    DOI 10.18614/deutip.1174477 Open-access full textSource: ORCID

  10. Are Hematologic Patients Trojan Horse for COVID-19?

    Indian Journal of Hematology and Blood Transfusion, 2022

    DOI 10.1007/s12288-021-01498-7 PMID 34667375 Open-access full textSource: ORCID

View all 51 publications